The syndrome score in the treatment group decreased significantly from 16.092.58 to 8.672.13 , while it changed insignificantly in the control group , with a significant difference in the lowering score between the two groups ( P < 0.05 ) ; the high quality rates of oocytes and embryos and clinical pregnancy rate were all superior in the treatment group to the control group ( 82.29 % vs 78.08 % , 76.76 % vs 68.79 % , 63.64 % vs 36.36 % , all P < 0.05 ) .